Company: MIRA
Filing Date: 2025-10-16
Form Type: 8-K
Source: 0001493152-25-018303
Chunk: 0

Company: MIRA PHARMACEUTICALS, INC.
Filing Date: 2025-10-16
Form: 8-K
Item: Item 8.01
Chunk 0
---
Item
8.01 Other Events

On
October 16, 2025, MIRA Pharmaceuticals, Inc. (the “ Company”), sold a total of 1,751,000 shares of its common stock, par value
$0.001, in block sales to multiple institutional investors, at an average price of $2.19 share (a 66% premium to the prior days
close), through its at-the-market equity offering facility (the “ Offering”). Gross proceeds from the Offering totaled approximately
$3,835,485 prior to deducting fees and expenses. The trades for the Offering were facilitated through Rodman & Renshaw, via the StockBlock
platform. The Offering did not include any warrants.

SIGNATURES

Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by
the undersigned hereunto duly authorized.

                        MIRA                                          
  Dated:                By:                        /s/                
                        Name:                      Erez               
                        Title:                     Chief